Radiopharmaceuticals Reference
- A radiopharmaceutical is two parts bolted together: a radioactive label that the camera can see, and a targeting molecule that decides where it goes.
- Technetium-99m (Tc-99m) is the workhorse of general nuclear medicine — short half-life, friendly photon energy, and it tags onto almost anything.
- The targeting molecule, not the radiation, is what makes a bone scan a bone scan and a HIDA scan a HIDA scan. Same camera, different chauffeur.
- PET uses positron emitters (most famously F-18 in FDG); standard scintigraphy and SPECT use single-photon emitters like Tc-99m.
- Match the half-life to the job: a quick scan tolerates a short half-life; therapy and slow biology need a longer-lived isotope.
Most of imaging shines energy into the body and reads the shadow that comes back. Nuclear medicine does the sneaky opposite: we inject a tiny radioactive tracer and let the body's own physiology carry it to the right spot, then we sit back and photograph the glow coming out. The whole field rests on one clever trick — a radiopharmaceutical — so this page is your cheat sheet for the usual suspects.
The two-part recipe
Every radiopharmaceutical is a partnership. Think of it as a glow-in-the-dark sticker stuck onto a homing pigeon.
- The radionuclide is the sticker. It emits the radiation the camera detects. By itself it has no opinion about where to go.
- The targeting ligand (or carrier molecule) is the pigeon. It knows the address — bone, bile, a tumor — and drags the sticker there.
Swap the pigeon and you change the whole study while keeping the same camera and the same physics. This is why one element, Tc-99m, can be the basis for a dozen completely different scans. If the radioactive-decay side of this feels shaky, it's worth a detour through radioactive decay and radiopharmaceuticals before you go further.
Why technetium-99m runs the show
Tc-99m is the golden retriever of nuclear medicine — eager, easy, and good with everyone. A few reasons it earned the crown:
- Its physical half-life is about 6 hours — long enough to do chemistry and image, short enough that the patient isn't radioactive all weekend.
- It emits a single 140 keV gamma photon, an energy the gamma camera detects beautifully without a punishing dose.
- It's pure gamma (no tagalong particle radiation to bump up the dose for no imaging benefit).
- It comes from a tabletop Mo-99/Tc-99m generator — the famous "moly cow" you milk each morning for a fresh dose.
The "m" in Tc-99m stands for metastable — an excited state that calmly sheds its extra energy as that handy 140 keV gamma, then settles down. It is not "modified" or "medical," however confidently someone says so on rounds.
The Tc-99m lineup (single-photon agents)
Here the pigeon does all the work. Same sticker, wildly different destinations.
| Agent | Where it goes / what it shows | Typical study |
|---|---|---|
| Tc-99m MDP (a diphosphonate) | Sticks to areas of active bone turnover | Bone scan |
| Tc-99m sestamibi | Taken up by metabolically busy tissue (heart muscle, parathyroid) | Cardiac perfusion; parathyroid |
| Tc-99m MAG3 / DTPA | Cleared by the kidneys | Renal function/drainage |
| Tc-99m HIDA (an IDA analog) | Extracted by hepatocytes into bile | HIDA (biliary) scan |
| Tc-99m MAA (macroaggregated albumin) | Lodges in lung capillaries | V/Q perfusion |
| Tc-99m sulfur colloid | Swept up by the reticuloendothelial system; maps lymph drainage | Liver/spleen; sentinel node |
Notice the pattern: the alphabet soup (MDP, MAG3, HIDA, MAA) is just the targeting molecule. Once you know the molecule's habit — bone, kidney, bile, lung — the study names itself. You're memorizing addresses, not chemistry.
Beyond technetium: the non-Tc players
Some jobs need a different isotope because of how it decays or how long it lingers.
| Radionuclide | Common form | Used for |
|---|---|---|
| I-123 | Sodium iodide | Thyroid imaging (diagnostic) |
| I-131 | Sodium iodide | Thyroid imaging and therapy (it emits a tissue-damaging beta particle) |
| Ga-67 / In-111 | Citrate / labeled white cells | Infection and inflammation imaging |
| Tl-201 | Thallous chloride | Older myocardial perfusion agent |
Iodine is the family that does double duty. I-123 is the gentle diagnostic twin; I-131 carries a beta particle that treats — same target (the thyroid), very different intent. Picking the wrong one is not a rounding error.
PET tracers are a different animal
PET uses positron emitters, not single-photon emitters. A positron meets an electron, both annihilate, and out fly two 511 keV photons in opposite directions — the camera catches that back-to-back pair. The star is F-18 FDG, a glucose look-alike that piles up in hungry, glucose-guzzling cells like many tumors. F-18 has a roughly 110-minute half-life, which is why a cyclotron-made tracer can still survive the drive to your scanner. Other PET tracers (Ga-68, F-18 labels for prostate and neuroendocrine targets) follow the same idea with different addresses.
Matching half-life to the mission
The single most useful instinct here: pick a half-life that fits the biology.
A too-short half-life decays away before slow physiology finishes (you photograph an empty room). A too-long one keeps irradiating the patient long after the picture is taken. The art is choosing a tracer whose clock matches how fast the target lights up — and remembering that physical half-life and biological clearance both shorten how long the signal actually lasts.
If you remember one thing, make it the recipe: sticker plus pigeon. Nail the targeting molecule and you've already named the study; the isotope just decides whether you're using a gamma camera, a SPECT system, or a PET scanner to watch the glow.